Transcontinental spread of multidrug-resistant Mycobacterium boris

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 2014-2017

  Long, Richard ^a,b,c,d   Nobert, Eva ^a,b,c   Chomyc, Sylvia ^a,b,c   Van Embden, Jan ^a,b,c   McNamee, Ciaran ^a,b,c   Duran, Rafael Rey ^a,b,c   Talbot, James ^a,b,c   Fanning, Anne ^a,b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; CYCLOSERINE; DALFOPRISTIN PLUS QUINUPRISTIN; ETHAMBUTOL; ETHIONAMIDE; GREPAFLOXACIN; IMIPENEM; ISONIAZID; KANAMYCIN; MEROPENEM; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; SPARFLOXACIN; THIOACETAZONE; TROVAFLOXACIN;

ADULT; ARTICLE; BACTERIUM ISOLATION; BIOPSY; CASE REPORT; CLINICAL FEATURE; DNA FINGERPRINTING; FEMALE; HISTOPATHOLOGY; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0032991542     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9809076     Document Type: Article

References (26)

1. 1. Pablos-Méndez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rie der, F. Bustreo, D. L. Cohn, C. S. B. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn, for the World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. 1998. Global surveillance for anti-tuberculosis drug resistance, 1994-97. N. Engl. J. Med. 338:1641-1649.
2. 2. Hersi, A., K. Elwood, R. Cowie, D. Kunimoto, and R. Long. 1999. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989-98. Can. Respir. J. (In press)
3. 3. Laboratory Biosafety Guidelines, 2nd ed. 1996. Laboratory Centre for Disease Control, Health Protection Branch, Health Canada.
4. 4. Master, R. N. 1992. Mycobacteriology. In Clinical Microbiology Procedures Handbook, Vol. 1. ASM, Washington, DC.
5. 5. Long, R., A. Fanning, R. Cowie, V. Hoeppner, M. FitzGerald, and the Western Canada Tuberculous Group. 1997. Antituberculous drug resistance in Western Canada (1993-1994). Can. Respir. J. 4:71-75.
6. 6. Kubica, G. P., and P. T. Kent. 1985. Public Health Mycobacteriology: A Guide for the Level III Laboratory. U.S. Department of Health and Human Services, Centers for Disease Control, Atlanta, GA.
7. 7. Heifets, L. et al. 1993. Radiometric broth macrodilution method for determination of minimal inhibitory concentrations (MIC) with Mycobacterium avium complex isolates. Proposed Guidelines, National Jewish Center for Immunology and Respiratory Diseases, Denver, CO.
8. 8. Kamerbeek, J., L. M. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, J. E. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
9. 9. Gutiérrez, M. C., E. Bouvet, J. Blásquez, and V. Vincent. 1998. Identification as Mycobacterium tuberculosis of previously described M. bovis multidrug-resistant strains [Letter]. Lancet 351:758.
10. 10. Schultsz, C., E. J. Kuijper, D. van Soolingen, and J. M. Prins. 1996. Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus. Clin. Infect. Dis. 23:841-843.
11. 11. Blásquez, J., L. E. Espinosa de Los Monteros, S. Samper, C. Martin, A. Guerrero, J. Cobo, J. van Embden, F. Baquerro, and E. Gómez-Mampaso. 1997. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J. Clin. Microbiol. 35:1390-1393.
12. 12. Samper, S., C. Martin, A. Pinedo, A. Rivero, J. Blásquez F. Baquerro, D. van Soolingen, and J. van Embden. 1997. Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS 11:1237-1242.
13. 13. Guerrero, A., J. Cobo, J. Fortún, E. Navas, C. Quereda, A. Asensio, J. Canón, J. Blásquez, and E. Gómez-Mampaso. 1997. Nosocomial transmission of Mycobacterium bovis resistant to eleven drugs in people with advanced HIV-1 infection. Lancet 350:1738-1742.
14. 14. Rouillon, A., S. Perdrizet, and R. Parrot. 1976. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 75:275-299.
15. 15. Dankner, W. M., N. J. Waecker, M. A. Essey, K. Moser, M. Thompson, and C. E. Davis. 1993. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine 72:11-37.
16. 16. O'Reilly, L. M., and C. J. Daborn. 1995. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tubercle Lung Dis. 76(Suppl. 1):1-46.
17. 17. Palenque, E., V. Villena, M. J. Rebolla, M. S. Jimenez, and S. Samper. 1998. Transmission of multidrug-resistant Mycobacterium bovis to an immunocompetent patient. Clin. Infect. Dis. 26:995-996.
18. 18. Pomerantz, M., L. Madsen, M. Goble, and M. D. Iseman. 1991. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann. Thorac. Surg. 52:1108-1112.
19. 19. Jouveshomme, S., B. Dautzenberg, H. Bakdach, and J.-P. Derenne. 1998. Preliminary results of collapse therapy with plombage for pulmonary disease caused by multidrug-resistant mycobacteria. Am. J. Respir. Crit. Care Med. 157:1609-1615.
20. 20. Gaensler, E. A. 1982. The surgery for pulmonary tuberculosis. Am. Rev. Respir. Dis. 125:73-84.
21. 21. Kent, D. C., and R. Schwartz. 1967. Active pulmonary tuberculosis with negative tuberculin skin tests. Am. Rev. Respir. Dis. 95:411-418.
22. 22. Rooney, J. J., Jr., J. A. Crocco, S. Kramer, and H. A. Lyons. 1976. Further observations on tuberculin reactions in active tuberculosis. Am. J. Med. 60:517-522.
23. 23. Orme, I. M., and F. M. Collins. 1984. Adoptive protection of the Mycobacterium tuberculosis-infected lung: dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity. Cell. Immunol. 84:113-120.
24. +) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J. Immunol. 148:2058-2061.
25. 25. McDyer, J. F., M. N. Hackley, T. E. Walsh, J. L. Cook, and R. A. Seder. 1997. Patients with multidrug-resistant tuberculosis with low CD4 T cell counts have impaired Th1 responses. J. Immunol. 158:492-500.
26. 26. Ellner, J. J. 1978. Suppressor adherent cells in human tuberculosis. J. Immunol. 121:2573-2579.